BACKGROUND AND OBJECTIVES

Evidence suggests that children and adolescents with avoidant/restrictive food intake disorder (ARFID) have heterogeneous clinical presentations. To use latent class analysis (LCA) and determine the frequency of various classes in pediatric patients with ARFID drawn from a 2-year surveillance study.

METHODS

Cases were ascertained using the Canadian Pediatric Surveillance Program methodology from January 1, 2016, to December 31, 2017. An exploratory LCA was undertaken with latent class models ranging from 1 to 5 classes.

RESULTS

Based on fit statistics and class interpretability, a 3-class model had the best fit: Acute Medical (AM), Lack of Appetite (LOA), and Sensory (S). The probability of being classified as AM, LOA, and S was 52%, 40.7%, and 6.9%, respectively. The AM class was distinct for increased likelihood of weight loss (92%), a shorter length of illness (<12 months) (66%), medical hospitalization (56%), and heart rate <60 beats per minute (31%). The LOA class was distinct for failure to gain weight (97%) and faltering growth (68%). The S class was distinct for avoiding certain foods (100%) and refusing to eat because of sensory characteristics of the food (100%). Using posterior probability assignments, a mixed group AM/LOA (n = 30; 14.5%) had characteristics of both AM and LOA classes.

CONCLUSIONS

This LCA suggests that ARFID is a heterogeneous diagnosis with 3 distinct classes corresponding to the 3 subtypes described in the literature: AM, LOA, and S. The AM/LOA group had a mixed clinical presentation. Clinicians need to be aware of these different ARFID presentations because clinical and treatment needs will vary.

What’s Known on the Subject:

Evidence suggests there is clinical heterogeneity in the presentation of children and adolescents with avoidant/restrictive food intake disorder (ARFID). However, no studies have clearly described subtype classifications in children and adolescents with ARFID.

What This Study Adds:

This study uses latent class analysis to demonstrate that ARFID is a heterogeneous diagnosis with 3 distinct classes, plus a mixed group with an overlapping symptom presentation, corresponding to clinical subtypes described in the literature.

Avoidant/restrictive food intake disorder (ARFID), a diagnosis in the Feeding and Eating Disorder section of the Diagnostic and Statistics Manual, Fifth Edition (DSM-5), represents an expanded revision of the DSM-IV criteria for Feeding Disorder of Infancy or Early Childhood.1  ARFID is an eating disorder that includes a heterogeneous collection of restrictive eating behaviors, including weight loss, poor growth, nutritional deficiency, dependence on oral or enteral supplements, and/or psychosocial impairment as a result of abnormal eating behaviors. Unlike anorexia nervosa (AN) or bulimia nervosa, patients with ARFID do not have body image concerns or fear of weight gain, although they may present to specialized eating disorder programs. Based on a surveillance study of Canadian pediatricians, the overall incidence of ARFID was 2.02 cases per 100 000, and the average age at presentation was 13.1 years.2  Current research and expert opinion support the existence of different ARFID presentations on the basis of the main drivers of food avoidance.310  Recent literature has described 3 examples of patients with ARFID:

  1. those with limited variety of intake secondary to sensory sensitivity;

  2. those with fear of aversive consequences from eating (eg, choking or vomiting); and

  3. those with an apparent lack of interest in eating.

As research exploring ARFID presentations has evolved, each of these outlined motivations for food restriction have been highlighted across different studies.1,6,11,12  Despite the recognition that clinical heterogeneity in the presentation of children and adolescents with ARFID exists, empirical data exploring distinct subtypes remains limited.

One recent retrospective chart review of patients with ARFID from a tertiary care eating disorder program described 3 descriptive presentations that aligned with the developmental descriptions noted above:

  1. 39% of the sample had weight loss and/or medical compromise as a consequence of apparent limited interest in eating or poor appetite;

  2. 18% of the sample restricted intake as a result of sensory sensitivity; and

  3. 43% restricted intake because of fear of aversive consequences of eating, such as fear of pain, nausea, or choking.6 

There was some overlap of ARFID subgroups, with 13% of the sample presenting with a mixed presentation. Another study reported on children with ARFID presenting to pediatric gastroenterology clinics: 58% presented in the low appetite subtype, 21% endorsed symptoms consistent with the sensory sensitivity subtype, and 9% met criteria for the fear of aversive consequences subtype.13  A retrospective chart review examining overlap of the 3 subtypes of ARFID reported that over half of individuals presenting to a specialized eating disorder program met criteria for >1 of the 3 proposed behavioral phenotypes of ARFID, providing further evidence that subtypes can co-occur.8  However, to date, studies that have attempted to group patients with ARFID have been limited to the experience of specialized treatment programs.

Latent class analysis (LCA) is a statistical method used to identify unobserved, mutually exclusive subgroups of individuals on the basis of common characteristics within a population. The fundamental assumption of LCA is that class membership can be explained by patterns of observed indicator variables. This methodology was used to identify categories of pediatric restrictive feeding and eating disorders using 3 different pediatric surveillance programs from around the globe.14  In each country, the LCA revealed 2 distinct clusters that mapped onto the DSM-5 criteria for AN and ARFID. This methodology was helpful in providing evidence that 2 separate clusters of restrictive feeding and eating disorders exist; that is, AN and ARFID, across 3 different countries, providing further diagnostic clarity of pediatric eating disorders.

To date, however, no studies have explored the presence or frequency of ARFID classes in a sample of children and adolescents with ARFID using LCA. Accordingly, the current study aims to use LCA to provide a preliminary investigation of the frequency and characteristics of various classes in a sample of children and adolescents with ARFID drawn from a 2-year surveillance study.

Cases for this study were ascertained through prospective active surveillance via a key informant design by the Canadian Pediatric Surveillance Program.15  The surveillance study period was from January 1, 2016, to December 31, 2017. Pediatricians from diverse clinical settings (community- and hospital-based) were surveyed monthly and asked to report on any new cases between 5 to 18 years of age who met the DSM-5 diagnostic criteria for ARFID and who presented for the first time in the previous month. Those who reported an incident case received a detailed questionnaire to establish the presence or absence of specific ARFID criteria; associated eating behaviors and symptoms; information on the medical, psychiatric, family, and social history; and the results of the physical examination and management of each case. A previously published study includes a description of the methodology and total sample, including the incidence and patient demographics and characteristics.2  The research ethics boards at SickKids, Toronto, Ontario, Canada, and the Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada, approved this study.

Exploratory Latent Class Analysis

An exploratory LCA approach was undertaken with latent class models, taking into consideration 1 to 5 classes. Because LCA is restricted to dichotomous variables, 19 initial differentiating indicators were identified from the available questionnaire data on the basis of expert opinions and previous literature descriptions. The indicators selected were 6 Boolean (yes/no) variables related to the diagnostic criteria1  (weight loss, failure to achieve expected weight gain, faltering growth, nutritional deficiency, dependence on enteral feeding or oral nutritional supplements, or marked interference with psychosocial functioning), along with 13 additional symptoms (length of illness [LOI] <12 months, somatic complaints, medical hospitalization, heart rate [HR] <60 beats per minute, difficulties swallowing, eating but not eating enough, not initiating eating, diagnosis of autism spectrum disorder [ASD], preoccupation with food/eating, feeding-associated symptoms that preceded the onset of the feeding difficulties [ie, choking or gagging], sensitivities based upon food sensory characteristics, general food avoidance, and the avoidance of certain foods).

The consistent Akaike information criterion, Bayesian information criterion, sample-size adjusted Bayesian information criterion, and entropy were examined and used to determine the most parsimonious model. An iterative process was then used to remove indicators that showed no discriminatory value (largest probability differences across classes of <15%) to retain a minimal set of important indicators to the proposed classes. The theoretical response probabilities for each indicator variable and overall class probabilities were calculated and presented in the results.

Posterior Probability Analysis

Class assignment probabilities were calculated for each of the 207 children and adolescents using the final model from the LCA; these probabilities are referred to as posterior probabilities. Given the pattern of uncertainty observed in the posterior probabilities, children and adolescents were subdivided into 4 groups. For clarity, throughout the remainder of the article, the term “class” will be used when referring to the theoretical findings from the initial LCA, and the term “groups” when referring to the analysis based on posterior probability assignment. Demographic and additional clinical variables were calculated for the groups. Significance testing was performed on variables of interest between groups. The analysis was completed using R 4.0.3 statistical software (R Core Team, 2021) and the polytomous variable LCA package.16 

A total of 207 children and adolescents aged 5 to 18 years (mean age = 13.1 years [SD = 3.2; range 5.0–17.8 years]) living in Canada were included.2 

Exploratory Latent Class Analysis Results

Based on fit statistics and class interpretability, modeling that included 16 signs and symptoms was the most parsimonious model and a 3-class model had the best overall fit (Supplemental Table 2). The 3 classes were named Acute Medical (AM), Lack of Appetite (LOA), and Sensory (S). The LCA prediction class membership probabilities reveal 52.4% probability of belonging to the AM class, 40.7% probability for LOA class, and 6.9% for S class (Fig 1). The AM class was distinct for having increased likelihood of weight loss (92%), a shorter LOI (<12 months) to presentation (66%), medical hospitalization (56%), and HR <60 beats per minute (31%). The LOA class was distinct for failure to gain weight (97%) and faltering growth (68%). In addition, this class had a greater probability of eating, but not enough, and not initiating eating. The S class was distinct from the other classes in that these patients avoided certain foods (100%) and refused to eat because of sensory characteristics of the food (100%).

FIGURE 1

Latent class model probabilities.

FIGURE 1

Latent class model probabilities.

Close modal

Posterior Probability Results

Posterior probability assignments resulted in 3 groups of participants where the posterior probabilities were strongly indicative of a single class (probability of 1 of the class assignments was >80%), and a fourth group that was composed of children and adolescents with a mixed-class assignment (class assignment probabilities between 20% and 80%). Of the 207 individuals with ARFID, 85.0% fit into 1 of 3 distinct posterior probability groups (Fig 2): 44.4% (n = 92) were assigned to the AM group, 33.8% (n = 70) to the LOA group, and 6.8% (n = 14) to the S group. There were 14.5% (n = 30) of individuals who presented with a mixture of both AM- and LOA (AM/LOA)-group characteristics and were assigned to a fourth group. There was 1 case (0.5%) that did not meet the 80% assignment threshold to be included in any group (indeterminate) and is not included in the remaining posterior probability analysis. Table 1 shows a descriptive analysis and comparison of these groups using additional variables. Observed differences across the AM, LOA, S, and AM/LOA groups were noted for the following variables: sex (P = .0001); age at diagnosis (P <.001), age at onset of symptoms (P <.001), LOI (P <.001), body mass index (BMI) z score (P <.001), HR (P <.001), and weight at presentation (P <.001).

FIGURE 2

Posterior probabilities and assignments.

FIGURE 2

Posterior probabilities and assignments.

Close modal
TABLE 1

Posterior Probability Class Descriptions

AMLOASAM/LOAP
N 92 70 14 30  
Sex, female (n, %) 64 (69.6) 40 (57.1) 2 (14.3) 20 (66.7) .001 
Age at diagnosis, y mean (SD) 13.98 (2.81) 12.80 (3.05) 7.79 (3.10) 13.29 (2.09) <.001 
Age at onset of symptoms, y mean (SD) 12.90 (2.93) 8.16 (4.80) 1.11 (1.02) 10.62 (3.39) <.001 
LOI, mo, mean (SD) 13.46 (19.16) 57.08 (44.47) 80.36 (32.04) 31.70 (37.80) <.001 
BMI z score, mean (SD) −1.40 (1.34) −2.21 (1.36) −0.17 (0.95) −1.73 (1.32) <.001 
HR at presentation, beats per minute, mean (SD) 69.88 (21.99) 85.17 (20.25) 83.62 (11.82) 83.19 (15.78) <.001 
Percentage TGW at presentation, mean (SD) 84.26 (9.74) 82.42 (9.99) 101.36 (12.75) 84.36 (10.06) <.001 
Medical comorbidity, n (%) 24 (27.0) 21 (30.9) 6 (42.9) 5 (16.7) .29 
Previous medical hospitalization, n (%) 17 (20.2) 13 (19.4) 2 (14.3) 4 (14.3) .88 
Previous psychiatric hospitalization, n (%) 3 (3.6) 3 (4.5) 0 (0.0) 0 (0.0) .60 
Psychiatric disorders, n (%) 
Depression 13 (15.7) 4 (6.3) 0 (0.0) 4 (15.4) .15 
Anxiety disorder 52 (62.7) 28 (43.8) 3 (27.3) 17 (58.6) .04 
Obsessive-compulsive disorder 7 (8.5) 9 (14.1) 0 (0.0) 1 (4.0) .25 
ADHD 9 (10.6) 19 (29.2) 0 (0.0) 3 (11.1) .005 
Substance use disorder 6 (6.7) 1 (1.5) 0 (0.0) 0 (0.0) .19 
Intellectual or cognitive impairment 4 (4.5) 6 (9.4) 1 (7.1) 2 (7.4) .69 
Other psychiatric disorders 17 (23.0) 10 (20.8) 0 (0.0) 3 (12.5) .28 
Gastrointestinal response to feeding or eating, n (%) 
Choking 18 (20.2) 3 (4.4) 1 (7.1) 5 (17.2) .03 
Gagging 10 (11.2) 2 (2.9) 7 (50.0) 4 (13.8) <.001 
Vomiting 21 (23.6) 7 (10.3) 1 (7.1) 1 (3.4) .02 
Swallowing 21 (23.6) 6 (9.0) 0 (0.0) 3 (10.0) .02 
Choking or vomiting or swallowing problems 37 (42.5) 14 (21.2) 2 (16.7) 8 (27.6) .02 
AMLOASAM/LOAP
N 92 70 14 30  
Sex, female (n, %) 64 (69.6) 40 (57.1) 2 (14.3) 20 (66.7) .001 
Age at diagnosis, y mean (SD) 13.98 (2.81) 12.80 (3.05) 7.79 (3.10) 13.29 (2.09) <.001 
Age at onset of symptoms, y mean (SD) 12.90 (2.93) 8.16 (4.80) 1.11 (1.02) 10.62 (3.39) <.001 
LOI, mo, mean (SD) 13.46 (19.16) 57.08 (44.47) 80.36 (32.04) 31.70 (37.80) <.001 
BMI z score, mean (SD) −1.40 (1.34) −2.21 (1.36) −0.17 (0.95) −1.73 (1.32) <.001 
HR at presentation, beats per minute, mean (SD) 69.88 (21.99) 85.17 (20.25) 83.62 (11.82) 83.19 (15.78) <.001 
Percentage TGW at presentation, mean (SD) 84.26 (9.74) 82.42 (9.99) 101.36 (12.75) 84.36 (10.06) <.001 
Medical comorbidity, n (%) 24 (27.0) 21 (30.9) 6 (42.9) 5 (16.7) .29 
Previous medical hospitalization, n (%) 17 (20.2) 13 (19.4) 2 (14.3) 4 (14.3) .88 
Previous psychiatric hospitalization, n (%) 3 (3.6) 3 (4.5) 0 (0.0) 0 (0.0) .60 
Psychiatric disorders, n (%) 
Depression 13 (15.7) 4 (6.3) 0 (0.0) 4 (15.4) .15 
Anxiety disorder 52 (62.7) 28 (43.8) 3 (27.3) 17 (58.6) .04 
Obsessive-compulsive disorder 7 (8.5) 9 (14.1) 0 (0.0) 1 (4.0) .25 
ADHD 9 (10.6) 19 (29.2) 0 (0.0) 3 (11.1) .005 
Substance use disorder 6 (6.7) 1 (1.5) 0 (0.0) 0 (0.0) .19 
Intellectual or cognitive impairment 4 (4.5) 6 (9.4) 1 (7.1) 2 (7.4) .69 
Other psychiatric disorders 17 (23.0) 10 (20.8) 0 (0.0) 3 (12.5) .28 
Gastrointestinal response to feeding or eating, n (%) 
Choking 18 (20.2) 3 (4.4) 1 (7.1) 5 (17.2) .03 
Gagging 10 (11.2) 2 (2.9) 7 (50.0) 4 (13.8) <.001 
Vomiting 21 (23.6) 7 (10.3) 1 (7.1) 1 (3.4) .02 
Swallowing 21 (23.6) 6 (9.0) 0 (0.0) 3 (10.0) .02 
Choking or vomiting or swallowing problems 37 (42.5) 14 (21.2) 2 (16.7) 8 (27.6) .02 

TGW, treatment goal weight.

The AM group was observed to have much shorter LOI to presentation (13.49 [± 19.16] months); lower HR (69.9 beats per minute ± 21.99 beats per minute); and higher incidence of choking (20.2%; 18 of 92), vomiting (23.6%; n = 21 of 92), and swallowing difficulties (23.6%; 21 of 92) preceding the onset of feeding difficulties. Anxiety (52%; 52 of 92) and depression (15.7%; 13 of 92) were also observed to be highest among the AM group compared with the other groups. The LOA group appeared to have the lowest BMI z score; lowest percentage treatment goal weight17 ; and highest proportion of individuals with attention-deficit/hyperactivity disorder (ADHD) (29.2%; 19 of 70) and “other psychiatric disorders” (Table 1). The highest proportion of males were observed in the S group (85.7%; 12 of 14). The S group also appeared to have the highest percentage of treatment goal weight at presentation (101.4 ± 12.8); a younger age at diagnosis (7.79 ± 3.10 years) and age at onset of symptoms (1.11 ± 1.02 years); higher proportion of comorbid medical problems (42.9%; 6 of 14); and gagging (50%; 7 of 14) that preceded the onset of feeding difficulties. The AM/LOA group was observed to have mixed symptoms, including having an average age at diagnosis (13.29 ± 2.09 years) and average duration of illness (31.7 ± 37.8 months) that fell between the 2 groups.

The current study used LCA to examine heterogeneity in the clinical presentation of children and adolescents with ARFID presenting to pediatricians from diverse clinical settings in Canada. Based on fit statistics and class interpretability, a 3-class model (AM, LOA, and S classes) yielded the best overall fit to the data. The 3-class solution bears important similarities to the accumulating work in this area.311  Despite identifying 3 classes in the LCA, our posterior probability analysis suggested a fourth mixed group. This supports the literature that “mixed presentations” may be present among children and adolescents with ARFID and the 3 presentations described above are not mutually exclusive8,12,18  (Fig 2).

The AM group identified in the posterior probability analysis is most similar to the fear of aversive consequences group described in the literature. Unlike individuals in the LOA or S group, those in the AM group included a higher proportion of individuals who were exposed to a reported potentially acute traumatic event, such as choking or vomiting, that preceded the feeding difficulties.19  Those in the AM group demonstrated a more rapid onset of symptoms, accompanied by distinct medical complications that required more immediate intervention, including hospitalization, compared with the other groups. In addition, this group had a higher proportion of anxiety. Evidence suggests that anxiety coupled with exposure to perceived acute traumatic events (eg, choking, vomiting) can increases one’s vulnerability to negative responses and may trigger the onset of feeding difficulties.12,2022  Although our questionnaire lacked sufficient ability to discriminate whether these potentially traumatic events correlated with the feeding disturbance, we hypothesized that the short duration of illness, higher weight loss, and medical hospitalizations supported the severity of presentation related to these events.

The LOA group identified in this study was most similar to those described by other recent studies as having lack of interest in food or eating, with features of failure to gain weight, faltering growth, eating but not enough, and not initiating eating. This group also had a younger age at diagnosis and longer duration of illness than the AM group, suggesting that feeding difficulties were already present at the onset of puberty, a time of increased energy requirements. Children and adolescents who have insufficient intake because of longstanding low appetite and indifference to food will not meet the increased energy needs of puberty, resulting in failure to gain weight and faltering growth. Another consideration for this group involves the association between early adolescence and increased autonomy and independence, which might predispose youth who resist supervised nutrition to lower intake on account of their lack of drive related to appetite. This group also exhibited high rates of anxiety, obsessive-compulsive disorder, and other mental health diagnoses. The lack of appetite and indifference to food may be compounded or exacerbated by the increased comorbid mental health issues. Further, almost a third of patients had comorbid ADHD (29.2%), raising the possibility that distractibility around meals or stimulant-induced appetite reduction may have further exacerbated their feeding difficulties.23  A recent study of food preferences, food neophobia, and chemosensation (smell and taste) in children and youth with ADHD found that those with ADHD were more likely to exhibit impaired chemosensation than the non-ADHD group, suggesting impaired chemosensory function might be another factor contributing to diminished eating pleasure and appetite among these youth.24  In addition, reduction in HR during periods of malnutrition is typically the result of increased vagal tone as a method of energy conservation in response to starvation. It has been shown that acute reductions in nutritional intake and rapid weight loss have a more profound effect on metabolic regulation of HR than chronic malnourishment.25  Compared with the AM group, the mean HR in the LOA group was 85.2 ± 20.3 beats per minute, suggesting a more chronic adaptation to inadequate nutrition.

The S group identified in this study was most similar to sensory sensitivity group described in the literature, with a high probability of avoidance of certain foods and refusal to eat because of dislike of certain sensory characteristics of foods. Our data suggest that the S group is a distinct, mutually exclusive group and does not seem to have mixed presentation with the AM or LOA group. Unlike those groups, there were few medical concerns identified in the S group. This group had a male predominance, younger age at presentation and diagnosis, and a longer duration of illness. Approximately half of this group was noted to have a history of gagging predating the onset of their feeding difficulties. Consistent with earlier studies in children with ARFID, sensitivity and fear of aversive reactions to sensations from various parts of the gastrointestinal tract (eg, esophageal sensitivity to feelings of gagging) have been noted to be a prevalent driver of food avoidance.6,26,27 This may explain why the aversive somatic experience of gagging may be overrepresented in this clinical sample who are presenting to pediatricians for assessment. In addition, this group had a higher probability of a diagnosis of ASD (29%). Previous studies have acknowledged the association between feeding disturbances among children with ASD.2834  A recent prospective study of children with ASD demonstrated feeding difficulties in 76% of cases, and that 28% met threshold criteria for ARFID.34 

The fourth group of individuals presented with mixed AM/LOA characteristics that spanned the continuum between the AM and LOA groups. This group may represent a group of young people with >1 driver of food avoidance, and/or children in the LOA group may migrate to the AM group when they enter puberty and are no longer able to meet the increasing energy needs. In addition, >50% of the AM/LOA group was noted to have comorbid anxiety (58.6%), and a high proportion of cases reported events that might have served as potential triggers for the feeding difficulty (17.2% and 13.8% had incidents of choking and gagging preceding the onset of the feeding difficulty, respectively), suggesting that any of these motivating drivers for feeding disturbance could be exerting impact separately.

To date, limited evidence-based approaches have shown that treatment variations have been suggested to address the needs of children and adolescents with different clinical presentations of ARFID.35  Further systematic treatment studies are needed to investigate the effectiveness of various treatments on these different clinical presentations of children and adolescents with ARFID.

The strengths of this study include the application of the highly rigorous Canadian Pediatric Surveillance Program methodology that enabled national, prospective, and active surveillance by pediatricians from diverse clinical settings in Canada. It represents one of the largest samples of children with ARFID assessed by pediatricians. To our knowledge, this is the first study to use LCA methodology to assess the heterogeneity of patients presenting with ARFID. A few limitations warrant consideration. Cases were identified on the basis of presentation to a pediatrician, which may have increased the likelihood of a medically-based presentation. This may explain a higher probability of cases within the AM group, and further explains the overall medical issues observed in this study. This Canadian pediatric study may not be generalizable to adult populations or other countries with different health care systems. Additionally, although the indicators used were based on the ARFID literature and expert opinion, additional indicators could reveal other sources of heterogeneity among patients with ARFID. Finally, the study questionnaire was developed before empirical data proposed various drivers for feeding disturbances observed in patients with ARFID; specifically, there were few questions that focused on correlates and timing of conditioned negative responses or phobias associated with feeding, types and course of enteral feeds required, and other feeding-specific information (eg, nature and course of swallowing difficulties).

In summary, this study of children and adolescents with ARFID presenting to pediatricians in Canada adds to the growing body of literature suggesting that ARFID is a heterogeneous diagnosis. Although our LCA suggests the presence of 3 distinct classes, corresponding to the 3 clinical subtypes described in the literature, further analysis revealed a mixed group with an overlapping symptom presentation. Clinicians need to be aware of these different ARFID presentations because clinical and treatment needs will vary. Future long-term follow-up studies will provide a better understanding of the overall clinical course of individuals with different ARFID presentations. This information will contribute to a greater understanding of the etiology, comorbidities, and serious risks associated with these various presentations, and will further the development of treatments that target the underlying drivers of feeding disturbance.

We thank Ross D. Crosby, PhD, Vice President for Research, Director of Biomedical Statistics at the Neuropsychiatric Research Institute, and Professor in the Department of Psychiatry and Behavioral Science at the University of North Dakota School of Medicine and Health Sciences, for his advice and assistance with the statistical analyses.

Drs Spettigue, Agostino, and Couturier conceptualized and designed the study; Dr Guimond conceptualized and designed the data, designed the data collection instruments, collected data, and conducted the initial analyses; Drs Katzman and Norris conceptualized and designed the study, designed the data collection instruments, collected data, conducted the initial analyses, coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content; and all authors drafted the initial manuscript, reviewed and revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.

FUNDING: Supported by the Canadian Pediatric Surveillance Program and Eat, Play, Think! Catalyst Grant, the Centre for Brain and Mental Health, and the Centre for Healthy Active Kids, University of Toronto and the W. Garfield Weston Foundation. The funder/sponsor did not participate in the work.

CONFLICT OF INTEREST DISCLAIMER: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

ADHD

attention-deficit/hyperactivity disorder

AM

Acute Medical

AM/LOA

Acute Medical and Lack of Appetite

AN

anorexia nervosa

ARFID

avoidant/restrictive food intake disorder

ASD

autism spectrum disorder

DSM-5

Diagnostic and Statistics Manual, Fifth Edition

HR

heart rate

LCA

latent class analysis

LOA

Lack of Appetite

LOI

length of illness

S

Sensory

1
American Psychiatric Association
.
Diagnostic and Statistical Manual of Mental Disorders
, 5th ed.
Arlington, Virginia
:
American Psychiatric Association
;
2013
2
Katzman
DK
,
Spettigue
W
,
Agostino
H
, et al
.
Incidence and age- and sex-specific differences in the clinical presentation of children and adolescents with avoidant restrictive food intake disorder
.
JAMA Pediatr
.
2021
;
175
(
12
):
e213861
3
Zickgraf
HF
,
Lane-Loney
S
,
Essayli
JH
,
Ornstein
RM
.
Further support for diagnostically meaningful ARFID symptom presentations in an adolescent medicine partial hospitalization program
.
Int J Eat Disord
.
2019
;
52
(
4
):
402
409
4
Makhzoumi
SH
,
Schreyer
CC
,
Hansen
JL
,
Laddaran
LA
,
Redgrave
GW
,
Guarda
AS
.
Hospital course of underweight youth with ARFID treated with a meal-based behavioral protocol in an inpatient-partial hospitalization program for eating disorders
.
Int J Eat Disord
.
2019
;
52
(
4
):
428
434
5
Rienecke
RD
,
Drayton
A
,
Richmond
RL
,
Mammel
KA
.
Adapting treatment in an eating disorder program to meet the needs of patients with ARFID: Three case reports
.
Clin Child Psychol Psychiatry
.
2020
;
25
(
2
):
293
303
6
Norris
ML
,
Spettigue
W
,
Hammond
NG
, et al
.
Building evidence for the use of descriptive subtypes in youth with avoidant restrictive food intake disorder
.
Int J Eat Disord
.
2018
;
51
(
2
):
170
173
7
Cimino
S
,
Marzilli
E
,
Babore
A
,
Trumello
C
,
Cerniglia
L
.
DAT1 and its psychological correlates in children with avoidant/restrictive food intake disorder: a cross-sectional pilot study
.
Behav Sci (Basel)
.
2021
;
11
(
1
):
9
8
Reilly
EE
,
Brown
TA
,
Gray
EK
,
Kaye
WH
,
Menzel
JE
.
Exploring the cooccurrence of behavioural phenotypes for avoidant/restrictive food intake disorder in a partial hospitalization sample
.
Eur Eat Disord Rev
.
2019
;
27
(
4
):
429
435
9
Sharp
WG
,
Stubbs
KH
.
Avoidant/restrictive food intake disorder: a diagnosis at the intersection of feeding and eating disorders necessitating subtype differentiation
.
Int J Eat Disord
.
2019
;
52
(
4
):
398
401
10
Bryant-Waugh
R
,
Markham
L
,
Kreipe
RE
,
Walsh
BT
.
Feeding and eating disorders in childhood
.
Int J Eat Disord
.
2010
;
43
(
2
):
98
111
11
Norris
ML
,
Spettigue
WJ
,
Katzman
DK
.
Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth
.
Neuropsychiatr Dis Treat
.
2016
;
12
:
213
218
12
Thomas
JJ
,
Lawson
EA
,
Micali
N
,
Misra
M
,
Deckersbach
T
,
Eddy
KT
.
Avoidant/restrictive food intake disorder: a three-dimensional model of neurobiology with implications for etiology and treatment
.
Curr Psychiatry Rep
.
2017
;
19
(
8
):
54
13
Eddy
KT
,
Thomas
JJ
,
Hastings
E
, et al
.
Prevalence of DSM-5 avoidant/restrictive food intake disorder in a pediatric gastroenterology healthcare network
.
Int J Eat Disord
.
2015
;
48
(
5
):
464
470
14
Pinhas
L
,
Nicholls
D
,
Crosby
RD
,
Morris
A
,
Lynn
RM
,
Madden
S
.
Classification of childhood onset eating disorders: a latent class analysis
.
Int J Eat Disord
.
2017
;
50
(
6
):
657
664
15
Canadian Paediatric Surveillance Program
.
Avoidant/restrictive food intake disorder
.
16
Linzer
DA
,
Lewis
JB
.
poLCA: an R package for polytomous variable latent class analysis
.
J Stat Softw
.
2011
;
42
(
10
):
1
29
17
Norris
ML
,
Hiebert
JD
,
Katzman
DK
.
Determining treatment goal weights for children and adolescents with anorexia nervosa
.
Paediatr Child Health
.
2018
;
23
(
8
):
551
552
18
Aloi
M
,
Sinopoli
F
,
Segura-Garcia
C
.
A case report of an adult male patient with avoidant/restrictive food intake disorder treated with CBT
.
Psychiatr Danub
.
2018
;
30
(
3
):
370
373
19
Thomas
JJ
,
Brigham
KS
,
Sally
ST
,
Hazen
EP
,
Eddy
KT
.
Case 18-2017–an 11-year-old girl with difficulty eating after a choking incident
.
N Engl J Med
.
2017
;
376
(
24
):
2377
2386
20
Duits
P
,
Cath
DC
,
Lissek
S
, et al
.
Updated meta-analysis of classical fear conditioning in the anxiety disorders
.
Depress Anxiety
.
2015
;
32
(
4
):
239
253
21
Lissek
S
,
Powers
AS
,
McClure
EB
, et al
.
Classical fear conditioning in the anxiety disorders: a meta-analysis
.
Behav Res Ther
.
2005
;
43
(
11
):
1391
1424
22
Waters
AM
,
Henry
J
,
Neumann
DL
.
Aversive Pavlovian conditioning in childhood anxiety disorders: impaired response inhibition and resistance to extinction
.
J Abnorm Psychol
.
2009
;
118
(
2
):
311
321
23
Pennell
A
,
Couturier
J
,
Grant
C
,
Johnson
N
.
Severe avoidant/restrictive food intake disorder and coexisting stimulant treated attention deficit hyperactivity disorder
.
Int J Eat Disord
.
2016
;
49
(
11
):
1036
1039
24
Stankovic
J
,
Hove Thomsen
P
,
Ovesen
T
.
Food preferences, food neophobia and chemosensation among adolescents with ADHD
.
Acta Paediatr
.
2021
;
110
(
7
):
2187
2199
25
DiVasta
AD
,
Walls
CE
,
Feldman
HA
, et al
.
Malnutrition and hemodynamic status in adolescents hospitalized for anorexia nervosa
.
Arch Pediatr Adolesc Med
.
2010
;
164
(
8
):
706
713
26
Dinkler
L
,
Yasumitsu-Lovell
K
,
Eitoku
M
, et al
.
Development of a parent-reported screening tool for avoidant/restrictive food intake disorder (ARFID): initial validation and prevalence in 4-7-year-old Japanese children
.
Appetite
.
2022
;
168
:
105735
27
Zucker
NL
,
LaVia
MC
,
Craske
MG
, et al
.
Feeling and body investigators (FBI): ARFID division-An acceptance-based interoceptive exposure treatment for children with ARFID
.
Int J Eat Disord
.
2019
;
52
(
4
):
466
472
28
Dovey
TM
,
Kumari
V
,
Blissett
J
.
Eating behaviour, behavioural problems and sensory profiles of children with avoidant/restrictive food intake disorder (ARFID), autistic spectrum disorders or picky eating: Same or different?
Eur Psychiatry
.
2019
;
61
:
56
62
29
Sharp
WG
,
Postorino
V
,
McCracken
CE
, et al
.
Dietary intake, nutrient status, and growth parameters in children with autism spectrum disorder and severe food selectivity: an electronic medical record review
.
J Acad Nutr Diet
.
2018
;
118
(
10
):
1943
1950
30
Inoue
T
,
Otani
R
,
Iguchi
T
, et al
.
Prevalence of autism spectrum disorder and autistic traits in children with anorexia nervosa and avoidant/restrictive food intake disorder
.
Biopsychosoc Med
.
2021
;
15
(
1
):
9
31
Zickgraf
HF
,
Richard
E
,
Zucker
NL
,
Wallace
GL
.
Rigidity and sensory sensitivity: Independent contributions to selective eating in children, adolescents, and young adults. [Published online ahead of print March 19, 2020]
.
J Clin Child Adolesc Psychol
.
2020
:
1
13
.
32
Farag
F
,
Sims
A
,
Strudwick
K
, et al
.
Avoidant/restrictive food intake disorder and autism spectrum disorder: clinical implications for assessment and management
.
Dev Med Child Neurol
.
2022
;
64
(
2
):
176
182
33
Lucarelli
J
,
Pappas
D
,
Welchons
L
,
Augustyn
M
.
Autism spectrum disorder and avoidant/restrictive food intake disorder
.
J Dev Behav Pediatr
.
2017
;
38
(
1
):
79
80
34
Nygren
G
,
Linnsand
P
,
Hermansson
J
,
Dinkler
L
,
Johansson
M
,
Gillberg
C
.
Feeding problems including avoidant restrictive food intake disorder in young children with autism spectrum disorder in a multiethnic population
.
Front Pediatr
.
2021
;
9
:
780680
35
Lock
J
,
Robinson
A
,
Sadeh-Sharvit
S
, et al
.
Applying family-based treatment (FBT) to three clinical presentations of avoidant/restrictive food intake disorder: Similarities and differences from FBT for anorexia nervosa
.
Int J Eat Disord
.
2019
;
52
(
4
):
439
446

Supplementary data